China Digest: New Vision, Coherent Biopharma snap funding

Shunwei Capital-backed New Vision has raised $28.7 million in a Series D round, while Coherent Biopharma has secured $100 million in Series B and B+ rounds.  

Related Keywords

Yangzhou ,Jiangsu ,China ,Shenzhen ,Guangdong ,Longding ,Shanghai ,Hefei ,Anhui ,Suzhou ,Shengdi ,Jilin ,Xinding ,Changjiang ,Huatai ,Jiangxi ,Chinese , ,Hefei Industry Investment Holding ,International Holdings ,Agricultural Bank ,Jiangsu Hengrui Pharmaceuticals ,Shanghai Alliance Investment ,Shunwei Capital Backed New Vision ,Huatai Zijin Investment ,Xunfei Capital ,Coherent Biopharma ,Hong Kong Listed Huatai Securities ,Changjiang Capital ,Longding Capital ,Xinding Capital ,Holdings Limited ,China Limited ,Suzhou Harvest Capital ,Hefei High Tech ,Frontline Bioventures ,